Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes

Lipids

Volumn 45, Issue 2, 2010, Pages 129-135

  Schlitt, Axel ^a   Schwaab, Bernhard ^b   Fingscheidt, Kirsten ^b   Lackner, Karl J ^c   Heine, Gunnar H ^d   Vogt, Alexander ^a   Buerke, Michael ^a   Maegdefessel, Lars ^a   Raaz, Uwe ^a   Werdan, Karl ^a   Jiang, Xian Cheng ^e  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Curschmann Clinic   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Phospholipid transfer protein

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY FAT; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE COURSE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

ADULT; AGED; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS; PROSPECTIVE STUDIES; TRIGLYCERIDES;

ANIMALIA;

EID: 77949263109     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-010-3384-5     Document Type: Article

References (30)

1. AR Tall S Krumholz T Olivecrona RJ Deckelbaum 1985 Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis J Lipid Res 26 842 851 1:CAS:528:DyaL2MXltVSms7o%3D 4031662
2. XC Jiang S Qin C Qiao K Kawano M Lin A Skold X Xiao AR Tall 2001 Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency Nat Med 7 847 852 10.1038/89977 1:CAS:528:DC%2BD3MXltVagtL4%3D 11433351 (Pubitemid 32691641)
3. XC Jiang AR Tall S Qin M Lin M Schneider F Lalanne V Deckert C Desrumaux A Athias JL Witztum L Lagrost 2002 Phospholipid transfer protein deficiency protects circulating lipo- proteins from oxidation due to the enhanced accumulation of vitamin E J Biol Chem 277 31850 31856 10.1074/jbc.M205077200 1:CAS:528:DC%2BD38XmslOqtbo%3D 12105225 (Pubitemid 34968992)
4. R van Haperen A van Tol T van Gent L Scheek P Visser A van der Kamp F Grosveld R de Crom 2002 Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein J Biol Chem 277 48938 48943 10.1074/jbc.M209128200 12372822 (Pubitemid 35470864)
5. J Lie R de Crom T van Gent R van Haperen L Scheek I Lankhuizen A van Tol 2002 Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion J Lipid Res 43 1875 1880 10.1194/jlr.M200166-JLR200 1:CAS:528:DC%2BD38Xos1yht70%3D 12401886 (Pubitemid 35315805)
6. A Schlitt C Bickel P Thumma S Blankenberg HJ Rupprecht J Meyer XC Jiang 2003 High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease Arterioscler Thromb Vasc Biol 23 1857 1862 10.1161/01.ATV.0000094433.98445.7F 1:CAS:528:DC%2BD3sXnslWit7o%3D 12947020 (Pubitemid 37254875)
7. W Schgoer T Mueller M Jauhiainen A Wehinger R Gander I Tancevski K Salzmann P Eller A Ritsch M Haltmayer C Ehnholm JR Patsch B Foeger 2008 Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis Atherosclerosis 196 219 226 10.1016/j.atherosclerosis.2007.04. 046 1:CAS:528:DC%2BD1cXpt1yqsQ%3D%3D 17553507
8. A Schlitt GH Heine XC Jiang M Messow S Blankenberg HJ Rupprecht C Ulrich M Buerke K Werdan KJ Lackner H Köhler M Girndt 2007 Phospholipid transfer protein (PLTP) in hemodialysis patients Am J Nephrol 27 138 143 10.1159/000099943 1:CAS:528:DC%2BD2sXktFemsbg%3D 17308375 (Pubitemid 46588178)
9. A Schlitt S Blankenberg C Bickel KJ Lackner GH Heine M Buerke K Werdan L Maegdefessel U Raaz HJ Rupprecht T Munzel XC Jiang 2009 PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study J Lipid Res 50 723 729 10.1194/jlr.M800414-JLR200 1:CAS:528:DC%2BD1MXks1Witrw%3D 19001358
10. SC Riemens A Van Tol WJ Sluiter RPF Dullaart 1998 Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipids transfer protein Atherosclerosis 140 71 79 10.1016/S0021-9150(98)00111-7 1:CAS:528:DyaK1cXks1Kkt7s%3D 9733217 (Pubitemid 28378456)
11. C Desrumaux A Athias G Bessède B Vergès M Farnier L Perségol P Gambert L Lagrost 1999 Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-treated diabetic subjects as measured by a specific ELISA Arterioscler Thromb Vasc Biol 19 266 275 1:STN:280: DyaK1M7ktFartQ%3D%3D 9974406
12. KC Tan SW Shiu Y Wong S Tam 2005 Plasma phospholipids transfer protein activity and subclinical inflammation in Type 2 diabetes mellitus Atherosclerosis 178 365 370 10.1016/j.atherosclerosis.2004.09.005 1:CAS:528:DC%2BD2MXhtVyjurk%3D 15754464 (Pubitemid 40193453)
13. HM Colhoun MR Taskinen JD Otvos P Van Den Berg J O'Connor A Van Tol 2002 Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without Type 1 diabetes Diabetes 51 3300 3305 10.2337/diabetes.51.11.3300 1:CAS:528:DC%2BD38Xos1ahtbw%3D 12401722
14. SC Riemens A van Tol WJ SluiterE RPF Dullaart 1998 Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients Diabetologia 41 929 934 10.1007/s001250051009 1:CAS:528:DyaK1cXltVGgtbk%3D 9726595 (Pubitemid 28365979)
15. SC Riemens A Van Tol WJ Sluiter RP Dullaart 1999 Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities J Lipid Res 40 1459 1466 1:CAS:528:DyaK1MXlt1Clsbc%3D 10428982
16. F Syeda C Senault B Delplanque B Le Roy A Thaminy D Gripois MF Blouquit A Ruelland F Mendy C Lutton 2003 Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men Nutr Metab Cardiovasc Dis 13 28 36 10.1016/S0939-4753(03)80165-5 1:CAS:528:DC%2BD3sXksVGltrs%3D 12772435 (Pubitemid 38561084)
17. N Mero A Van Tol LM Scheek T Van Gent C Labeur M Rosseneu MR Taskinen 1998 Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities J Lipid Res 39 1493 1502 1:CAS:528:DyaK1cXkslOquro%3D 9684753
18. XC Jiang C Bruce J Mar M Lin Y Ji OL Francone AR Tall 1999 Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels J Clin Invest 103 907 914 10.1172/JCI5578 1:CAS:528:DyaK1MXhvFarsrk%3D 10079112
19. SI McFarlane M Banerji JR Sowers 2001 Insulin resistance and cardiovascular disease J Clin Endocrinol Metab 86 713 718 10.1210/jc.86.2.713 1:CAS:528:DC%2BD3MXht1Knt7s%3D 11158035 (Pubitemid 32207485)
20. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234 10.1056/NEJM199807233390404 1:STN:280:DyaK1czivVKgsg%3D%3D 9673301 (Pubitemid 28350165)
21. R de Vries G Dallinga-Thie A Smit B Wolffenbuttel A van Tol R Dullaart 2006 Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in Type 2 diabetes mellitus Diabetologia 49 398 404 10.1007/s00125-005-0088-0 16374627 (Pubitemid 43185411)
22. U Julius M Jauhiainen C Ehnholm J Pietzsch 2007 Lipid transfer protein activities in subjects with impaired glucose tolerance Clin Chem Lab Med 45 237 243 10.1515/CCLM.2007.032 1:CAS:528:DC%2BD2sXjtFylsLc%3D 17311515 (Pubitemid 46294683)
23. RP Dullaart R de Vries GM Dallinga-Thie WJ Sluiter A van Tol 2008 Phospholipid transfer protein activity is determined by Type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases Clin Endocrinol (Oxf) 68 375 381 1:CAS:528:DC%2BD1cXktVajsbc%3D
24. PH Oomen A van Tol H Hattori AJ Smit LM Scheek RP Dullaart 2005 Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus Diabet Med 22 768 774 10.1111/j.1464-5491.2005.01521.x 1:CAS:528:DC%2BD2MXlvVGhtL0%3D 15910630 (Pubitemid 40805900)
25. SC Riemens A Van Tol WJ Sluiter RPF Dullaart 1999 Plasma phospholipids transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in Type 2 diabetic patients Diabetes 48 1631 1637 10.2337/diabetes.48.8.1631 1:CAS:528:DyaK1MXkvVKmsrg%3D 10426383 (Pubitemid 29356873)
26. HM Colhoun LM Scheek MB Rubens T Van Gent SR Underwood JH Fuller A Van Tol 2001 Lipid transfer protein activities in Type 1 diabetic patients without renal failure and non-diabetic control subjects and the association with coronary artery calcification Diabetes 50 652 659 10.2337/diabetes.50.3.652 1:CAS:528:DC%2BD3MXhslGgsLk%3D 11246887
27. AR Tall F Lalanne 2003 Phospholipid transfer protein and atherosclerosis Arterioscler Thromb Vasc Biol 23 1484 1485 10.1161/01.ATV.0000089080.76134.CE 1:CAS:528:DC%2BD3sXovVykt7Y%3D 12972459 (Pubitemid 37108186)
28. A Schlitt MR Hojjati H von Gizycki KJ Lackner S Blankenberg B Schwaab J Meyer HJ Rupprecht XC Jiang 2005 Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles J Lipid Res 46 196 200 10.1194/jlr.C400011-JLR200 1:CAS:528:DC%2BD2MXhvFGktbs%3D 15547302 (Pubitemid 40271082)
29. M Syvänne H Hilden MR Taskinen 1994 Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease J Lipid Res 35 15 26 8138716
30. V Durlach N Attia A Zahouani M Leutenegger A Girard-Globa 1996 Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients Atherosclerosis 120 155 165 10.1016/0021-9150(95)05697-1 1:CAS:528:DyaK28XlvVCmsg%3D%3D 8645357 (Pubitemid 26053315)